By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

American Society of Nephrology 

1510 H Street, NW
Suite 800
Washington  D.C.  20006  U.S.A.
Phone: 202-659-0599 Fax: 202-659-0709


SEARCH JOBS








Company News
Relypsa, Inc. Reports the Presentation of its Two-Part Pivotal Phase 3 Patiromer Trial in American Society of Nephrology Late-Breaker Poster 11/10/2013 12:32:17 AM
AM-Pharma Holding BV Presents Positive Data From recAP Preclinical Study at American Society of Nephrology Meeting 11/8/2013 9:54:08 AM
La Jolla Pharmaceutical Company (LJPC) Presents Data at the Annual American Society of Nephrology (ASN) Conference 11/7/2013 8:14:29 AM
NxStage Medical, Inc. (NXTM) Introduces New Products at 2013 American Society of Nephrology Meeting 11/7/2013 6:31:52 AM
FibroGen, Inc. to Present Data for Roxadustat (FG-4592), an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Oral Presentations at American Society of Nephrology - Kidney Week 2013 11/5/2013 7:08:37 AM
Kibow Biotech, Inc. Showcases Renadyl™ During Kidney Week American Society of Nephrology Convention in Atlanta Nov. 7-9 11/4/2013 7:14:54 AM
DaVita Clinical Research Studies Presented in Six Posters and Three Oral Presentations at American Society of Nephrology’s Kidney Week 11/4/2013 6:50:53 AM
Keryx Biopharmaceuticals (KERX)' Zerenex™ (Ferric Citrate Coordination Complex) Data Selected for Oral and Poster Presentations at the American Society of Nephrology's Kidney Week 2013 10/17/2013 9:42:41 AM
Alexion Pharmaceuticals Inc. (ALXN) Researchers to Present New Data on Soliris® (eculizumab) as a Treatment for Patients With aHUS at American Society of Nephrology Annual Meeting 10/16/2013 10:32:07 AM
Alexion Pharmaceuticals Inc. (ALXN) Release: Researchers to Present New Data on Soliris® (eculizumab) as a Treatment for Patients with aHUS at American Society of Nephrology Annual Meeting 10/16/2013 10:06:16 AM
12345678
//-->